{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:19:10Z","timestamp":1791152350976,"version":"4.1.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Background: Clinical presentation and disease severity in disorders of purine and pyrimidine metabolism vary considerably. We present a method that allows comprehensive, sensitive, and specific diagnosis of the entire spectrum of abnormalities in purine and pyrimidine metabolism in 1 analytical run.<\/jats:p><jats:p>Methods: We used reversed-phase HPLC electrospray ionization tandem mass spectrometry to investigate 24 metabolites of purine and pyrimidine metabolism in urine samples from healthy persons and from patients with confirmed diagnoses of inherited metabolic disorders. Urine samples were filtered and diluted to a creatinine concentration of 0.5 mmol\/L. Stable-isotope\u2013labeled internal standards were used for quantification. The metabolites were analyzed by multiple-reaction monitoring in positive and negative ionization modes.<\/jats:p><jats:p>Results: Total time of analysis was 20 min. Recovery (n = 8) of a compound after addition of a known concentration was 85%\u2013133%. The mean intraday variation (n = 10) was 12%. The interday variation (n = 7) was \u226417%. Age-related reference intervals were established for each compound. Analysis of patient urine samples revealed major differences in tandem mass spectrometry profiles compared with those of control samples. Twelve deficiencies were reliably detected: hypoxanthine guanine phosphoribosyl transferase, xanthine dehydrogenase, purine nucleoside phosphorylase, adenylosuccinate lyase, uridine monophosphate synthase, adenosine deaminase, adenine phosphoribosyl transferase, molybdenum cofactor, thymidine phosphorylase, dihydropyrimidine dehydrogenase, dihydropyrimidinase, and \u03b2-ureidopropionase.<\/jats:p><jats:p>Conclusion: This method enables reliable detection of 13 defects in purine and pyrimidine metabolism in a single analytical run.<\/jats:p>","DOI":"10.1373\/clinchem.2005.058842","type":"journal-article","created":{"date-parts":[[2006,4,14]],"date-time":"2006-04-14T00:47:04Z","timestamp":1144975624000},"page":"1127-1137","source":"Crossref","is-referenced-by-count":70,"title":["Comprehensive Detection of Disorders of Purine and Pyrimidine Metabolism by HPLC with Electrospray Ionization Tandem Mass Spectrometry"],"prefix":"10.1093","volume":"52","author":[{"given":"Susen","family":"Hartmann","sequence":"first","affiliation":[{"name":"Division of Metabolic Diseases, Department of General Pediatrics, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju\u0308rgen G","family":"Okun","sequence":"first","affiliation":[{"name":"Division of Metabolic Diseases, Department of General Pediatrics, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Schmidt","sequence":"first","affiliation":[{"name":"Division of Metabolic Diseases, Department of General Pediatrics, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Dieter","family":"Langhans","sequence":"first","affiliation":[{"name":"Division of Metabolic Diseases, Department of General Pediatrics, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven F","family":"Garbade","sequence":"first","affiliation":[{"name":"Division of Metabolic Diseases, Department of General Pediatrics, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Burgard","sequence":"first","affiliation":[{"name":"Division of Metabolic Diseases, Department of General Pediatrics, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Haas","sequence":"first","affiliation":[{"name":"Division of Metabolic Diseases, Department of General Pediatrics, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u0308rn Oliver","family":"Sass","sequence":"first","affiliation":[{"name":"Laboratory of Metabolism, Department of General Pediatrics and Adolescent Medicine, University Children\u2019s Hospital Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L","family":"Nyhan","sequence":"first","affiliation":[{"name":"University of California, San Diego, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg F","family":"Hoffmann","sequence":"first","affiliation":[{"name":"Division of Metabolic Diseases, Department of General Pediatrics, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,6,1]]},"reference":[{"key":"2020022801305046100_R1","doi-asserted-by":"crossref","unstructured":"Huang M, Graves LM. De novo synthesis of pyrimidine nucleotides; emerging interfaces with signal transduction pathways. Cell Mol Life Sci2002;60:321-336.","DOI":"10.1007\/s000180300027"},{"key":"2020022801305046100_R2","doi-asserted-by":"crossref","unstructured":"Simmonds HA, Duley JA, Fairbanks LD, McBride MB. When to investigate for purine and pyrimidine disorders: introduction and review of clinical and laboratory indications. J Inherit Metab Dis1997;20:214-226.","DOI":"10.1023\/A:1005308923168"},{"key":"2020022801305046100_R3","doi-asserted-by":"crossref","unstructured":"van Gennip AH, Abeling NG, Vreken P, van Kuilenburg AB. Inborn errors of pyrimidine degradation: clinical, biochemical, and molecular aspects. J Inherit Metab Dis1997;20:203-213.","DOI":"10.1023\/A:1005356806329"},{"key":"2020022801305046100_R4","doi-asserted-by":"crossref","unstructured":"Jaeken J, Van den Berghe G. An infantile autistic syndrome characterized by the presence of succinylpurines in body fluids. Lancet1984;2:1058-1061.","DOI":"10.1016\/S0140-6736(84)91505-8"},{"key":"2020022801305046100_R5","unstructured":"Henry RJ. Non-protein nitrogenous constituents. Clinical Chemistry, Principles and Technics1964:292-299 Hoeber Medical Division, Harper & Row New York. ."},{"key":"2020022801305046100_R6","doi-asserted-by":"crossref","unstructured":"Lahti A, Hyltoft Petersen P, Boyd JC, Fraser CG, Jorgensen N. Objective criteria for partitioning Gaussian-distributed reference values into subgroups. Clin Chem2002;48:338-352.","DOI":"10.1093\/clinchem\/48.11.1987"},{"key":"2020022801305046100_R7","doi-asserted-by":"crossref","unstructured":"Olsson U. Confidence intervals for the mean of a log-normal distribution. J Stat Educ2005;13www.amstat.org\/publications\/jse\/v13n1\/olsson.html (accessed January 2006)..","DOI":"10.1080\/10691898.2005.11910638"},{"key":"2020022801305046100_R8","doi-asserted-by":"crossref","unstructured":"Limpert E, Stahel WA, Abbt M. Log-normal distributions across the sciences: keys and clues. Bioscience2001;51:341-352.","DOI":"10.1641\/0006-3568(2001)051[0341:LNDATS]2.0.CO;2"},{"key":"2020022801305046100_R9","unstructured":". R Development Core Team. R: a language and environment for statistical computing2005 R Foundation for Statistical Computing Vienna, Austria. http:\/\/www.R-project.org (accessed February 2006).."},{"key":"2020022801305046100_R10","doi-asserted-by":"crossref","unstructured":"Blau N, Duran M, Blaskovics ME, Gibson KM. Physician\u2019s Guide to the Laboratory Diagnosis of Metabolic Diseases, 2nd ed2003:458 Springer Verlag Berlin. .","DOI":"10.1007\/978-3-642-55878-8"},{"key":"2020022801305046100_R11","doi-asserted-by":"crossref","unstructured":"Kuhara T, Ohdoi C, Ohse M. Simple gas chromatographic-mass spectrometric procedure for diagnosing pyrimidine degradation defects for prevention of severe anticancer side effects. J Chromatogr B Biomed Sci Appl2001;758:61-74.","DOI":"10.1016\/S0378-4347(01)00143-8"},{"key":"2020022801305046100_R12","doi-asserted-by":"crossref","unstructured":"Hofmann U, Schwab M, Seefried S, Marx C, Zanger UM, Eichelbaum M, et al. Sensitive method for the quantification of urinary pyrimidine metabolites in healthy adults by gas chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci2003;791:371-380.","DOI":"10.1016\/S1570-0232(03)00251-4"},{"key":"2020022801305046100_R13","doi-asserted-by":"crossref","unstructured":"Wevers RA, Engelke UFH, Moolenaar SH, Bra\u0308utigam C, de Jong JGN, Duran R, et al. 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin Chem1999;45:539-548.","DOI":"10.1093\/clinchem\/45.4.539"},{"key":"2020022801305046100_R14","doi-asserted-by":"crossref","unstructured":"Adam T, Friedecky D, Fairbanks LD, Secvik J, Bartak P. Capillary electrophoresis for detection of inherited disorders of purine and pyrimidine metabolism. Clin Chem1999;45:2086-2093.","DOI":"10.1093\/clinchem\/45.12.2086"},{"key":"2020022801305046100_R15","doi-asserted-by":"crossref","unstructured":"Frycak P, Huskova R, Adam T, Lemr K. Atmospheric pressure ionization mass spectrometry of purine and pyrimidine markers of inherited metabolic disorders. J Mass Spectrom2002;37:1242-1248.","DOI":"10.1002\/jms.389"},{"key":"2020022801305046100_R16","doi-asserted-by":"crossref","unstructured":"Ito T, van Kuilenburg ABP, Bootsma AH, Haasnoot AJ, van Cruchten A, Wada Y, et al. Rapid screening of high-risk patients for disorders of purine and pyrimidine metabolism using HPLC-electrospray tandem mass spectrometry of liquid urine or urine-soaked filter paper strips. Clin Chem2000;46:445-452.","DOI":"10.1093\/clinchem\/46.4.445"},{"key":"2020022801305046100_R17","doi-asserted-by":"crossref","unstructured":"van Lenthe H, van Kuilenburg ABP, Ito T, Bootsma AH, van Cruchten A, Wada Y, et al. Defects in pyrimidine degradation identified by HPLC-electrospray tandem mass spectrometry of urine specimens or urine-soaked filter paper strips. Clin Chem2000;46:1916-1922.","DOI":"10.1093\/clinchem\/46.12.1916"},{"key":"2020022801305046100_R18","doi-asserted-by":"crossref","unstructured":"van Kuilenburg AB, van Lenthe H, Loffler M, van Gennip AH. Analysis of pyrimidine synthesis \u201cde novo\u201d intermediates in urine and dried urine filter-paper strips with HPLC-electrospray tandem mass spectrometry. Clin Chem2004;50:2117-2124.","DOI":"10.1373\/clinchem.2004.038869"},{"key":"2020022801305046100_R19","doi-asserted-by":"crossref","unstructured":"van Kuilenburg AB, van Lenthe H, van Cruchten A, Kulik W. Quantification of 5,6-dihydrouracil by HPLC-electrospray tandem mass spectrometry. Clin Chem2004;50:236-238.","DOI":"10.1373\/clinchem.2003.026229"},{"key":"2020022801305046100_R20","doi-asserted-by":"crossref","unstructured":"Van den Berghe G, Vincent MF, Jaeken J. Inborn errors of the purine nucleotide cycle: adenylosuccinase deficiency. J Inherit Metab Dis1997;20:193-202.","DOI":"10.1023\/A:1005304722259"},{"key":"2020022801305046100_R21","doi-asserted-by":"crossref","unstructured":"Laikind PK, Seegmiller JE, Gruber HE. Detection of 5\u2032-phosphoribosyl-4-(N-succinylcarboxamide)-5-aminoimidazole in urine by use of the Bratton-Marshall reaction: identification of patients deficient in adenylosuccinate lyase activity. Anal Biochem1986;156:81-90.","DOI":"10.1016\/0003-2697(86)90158-2"},{"key":"2020022801305046100_R22","doi-asserted-by":"crossref","unstructured":"Marie S, Heron B, Bitoun P, Timmerman T, Van den Berghe G, Vincent MF. AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC. Am J Hum Genet2004;74:1276-1281.","DOI":"10.1086\/421475"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/52\/6\/1127\/32686343\/clinchem1127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/52\/6\/1127\/32686343\/clinchem1127.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T16:58:25Z","timestamp":1627232305000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/52\/6\/1127\/5626936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,1]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,6,1]]},"published-print":{"date-parts":[[2006,6,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2005.058842","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,6,1]]},"published":{"date-parts":[[2006,6,1]]}}}